WS #14242

From 464 msgs · 5 key-dev
Holding: newest synthesis is 90d 16h old

Argenx shares jumped after positive Phase 3 results for Vyvgart in autoimmune myositis, a high-significance biotech catalyst.

Argenx positive Phase 3 results

Argenx shares jumped after positive Phase 3 results for Vyvgart in autoimmune myositis, a high-significance biotech catalyst.

Full world state #14242 →